• Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Home > Publishers > GBI Research
Publisher
Filter

GBI Research Report List

GBI Research provides industry-leading global business intelligence solutions. Our products and services help companies make better business decisions, win business and position themselves more effectively. GBI Research publishes more than 100 research reports per annum across a wide range of industries. Our reports draw on in-depth primary and secondary research, databases of proprietary in-house data and high quality analysis from our expert teams. GBI Research employs hundreds of highly qualified Analysts across the US, Europe and Asia. Key report types currently published by GBI Research include: ? Market Intelligence Reports: premium analytical reports based on a combination of market data, company, deals and project content, industry surveys and additional primary and secondary research. ? Benchmarking Reports: analytical reports comparing key financial indicators for the top 20 companies in a particular industry and geography. ? Industry Outlook Reports: survey-based reports, revealing and analyzing the leading experts' opinions on the future of the industry covered. ? Market Profiles: overview-level reports based on market, company and demographic data. ? Pipeline Analysis Reports: reports analyzing the unmet need, market size and product pipeline for different disease indications, based on a detailed database of developmental products.

New for 2017!
Filter
Title Search
1 - 25 of 159 Products Sort by Display
Neuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
537172
Published
August 1, 2017
Content info
254 Pages
Price
USD 3995
Sample available
Hepatitis Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
537171
Published
August 1, 2017
Content info
209 Pages
Price
USD 3995
Sample available
Genetic Ophthalmology Disorders Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
537170
Published
August 1, 2017
Content info
138 Pages
Price
USD 3995
Sample available
Global Dermatology Drugs Market to 2023 - Growth Driven by Increased Uptake of Interleukin Receptor Inhibitors for Psoriasis and Atopic Dermatitis
Published by
GBI Research
Product code
540334
Published
July 1, 2017
Content info
136 Pages
Price
USD 4995
Sample available
Pharmaceutical Deal Trends 2017 Factbook: Partnerships and Acquisitions Shift Focus Towards Early Stage Development, Emerging Markets, and Biologics
Published by
GBI Research
Product code
531729
Published
July 1, 2017
Content info
 
Price
USD 2995
Sample available
Transplantation Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
524529
Published
July 1, 2017
Content info
242 Pages
Price
USD 3995
Sample available
Skeletal Disease Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
524528
Published
July 1, 2017
Content info
176 Pages
Price
USD 3995
Sample available
Pain Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
524527
Published
July 1, 2017
Content info
229 Pages
Price
USD 3995
Sample available
Colorectal Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market
Published by
GBI Research
Product code
318827
Published
July 1, 2017
Content info
143 Pages
Price
USD 4995
Sample available
Global Oncology Market to 2023 - Robust Growth Driven by Rising Prevalence and Increased Uptake of Immune Checkpoint Inhibitors
Published by
GBI Research
Product code
530489
Published
June 13, 2017
Content info
420 Pages
Price
USD 4995
Sample available
Frontier Pharma: Dermatology - Intracellular Signal Transducers and Cytokine Signaling Molecules Dominate Pipeline and First-in-Class Innovation
Published by
GBI Research
Product code
524531
Published
June 1, 2017
Content info
98 Pages
Price
USD 6995
Sample available
Global Pain Therapeutics Market to 2023 - Innovative New Products to Address Unmet Need within Chronic Pain and Migraine, and Tackle Opioid Abuse
Published by
GBI Research
Product code
524530
Published
June 1, 2017
Content info
147 Pages
Price
USD 4995
Sample available
Asthma Therapeutics in Asia-Pacific Markets to 2023 - High Prevalence and Highly Priced Existing & Upcoming Biologics will Drive the Market
Published by
GBI Research
Product code
520763
Published
June 1, 2017
Content info
134 Pages
Price
USD 4995
Sample available
Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation
Published by
GBI Research
Product code
326290
Published
June 1, 2017
Content info
70 Pages
Price
USD 6995
Sample available
Renal Cluster Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
503694
Published
May 11, 2017
Content info
181 Pages
Price
USD 3995
Sample available
Women's Health Cluster Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
503693
Published
May 10, 2017
Content info
123 Pages
Price
USD 3995
Sample available
Toxicology Cluster Chemotherapy Related Toxicity Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
503692
Published
May 9, 2017
Content info
139 Pages
Price
USD 3995
Sample available
Genetic Disorder Cluster Muscular Dystrophy Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
503691
Published
May 8, 2017
Content info
79 Pages
Price
USD 3995
Sample available
CNS Cluster Addiction Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
503690
Published
May 8, 2017
Content info
150 Pages
Price
USD 3995
Sample available
Frontier Pharma: First-in-Class Innovation in Hematological Cancers - Cytokine Signaling and Kinase Targeted Immunotherapies Dominate a Large and Highly Versatile Pipeline
Published by
GBI Research
Product code
512859
Published
May 3, 2017
Content info
84 Pages
Price
USD 6995
Sample available
Global Immunology Drugs Market to 2022 - Increasing Prevalence, Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive Growth
Published by
GBI Research
Product code
516017
Published
May 1, 2017
Content info
140 Pages
Price
USD 4995
Sample available
Frontier Pharma: Alzheimer's Disease and Associated Indications - Exceptional Level of First-in-Class Innovation within AD, and Diverse Range of Therapies in Development for Disorders Such as Anxiety and Depression
Published by
GBI Research
Product code
512858
Published
May 1, 2017
Content info
101 Pages
Price
USD 6995
Sample available
Breast Cancer Therapeutics in Southeast Asia Markets to 2022 - Increasing Prevalence and Usage of Premium Targeted Therapies to Drive the Market
Published by
GBI Research
Product code
498258
Published
April 1, 2017
Content info
176 Pages
Price
USD 4995
Sample available
Rheumatoid Arthritis Therapeutics in South-East Asia Markets to 2022 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs
Published by
GBI Research
Product code
498257
Published
April 1, 2017
Content info
140 Pages
Price
USD 4995
Sample available
Antibacterial Therapies Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
485008
Published
March 22, 2017
Content info
418 Pages
Price
USD 3995
Sample available